BioSpace News Archive

Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $8 million in funding through a new grant program in the United States called Gilead Relink, which is focused on bringing diagnosed but untreated people living with hepatitis C virus (HCV) or hepatitis B virus (HBV) back into care.

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its Q2 2023 business and financial highlights before the opening of the market on July 27, 2023.

Quest Diagnostics, through the Quest for Health Equity initiative, has teamed up with Western University of Health Sciences to offer no-cost diagnostic testing services to support Biopsies Save Lives.

A new video series from the Alliance for Aging Research—Expert Conversations on Neuropsychiatric Symptoms of Alzheimer’s—is now available to help shake the stigma of talking about neuropsychiatric symptoms (NPS) and to help those living with Alzheimer’s disease create a care plan and get the support they deserve.

Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, today announced it will report financial results for the second quarter ended June 30, 2023, after the market close on Thursday, August 3, 2023.

Codexis, Inc. announced that, in alignment with its previously announced strategy to focus resources on programs with the strongest probability of creating significant value in the near-term and beyond, the Company intends to prioritize the advancement and commercialization of its Enzyme-Catalyzed Oligonucleotide Synthesis™ platform and its highly complementary Pharmaceutical Manufacturing business.

OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 second quarter financial results and certain business developments for 5:00 pm ET on Thursday, August 3, 2023.

Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its second quarter 2023 financial results after the close of the market on Tuesday, August 8, 2023 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.

LIXTE Biotechnology Holdings, Inc. announced the closing of its previously announced registered direct offering of 583,334 shares of common stock and concurrent private placement of common warrants to purchase up to 583,334 shares of common stock at a purchase price of $6.00 per common share, priced “at-the-market” under Nasdaq rules.

Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced financial results for the quarter ended June 30, 2023.